Eating disorders are on the rise. GLP-1s could make things worse.
While GLP-1 drugs are a biotech breakthrough, some specialists report an increase in patients misusing these medications. This comes amid a reported 71% rise in anorexia and bulimia between 1990 and 2023.
Key points
- Global incidence of anorexia and bulimia rose 71% from 1990 to 2023
- Psychologists observe GLP-1 drugs potentially triggering or worsening eating disorders
- Concerns over the misuse of weight-loss medications
Summary and key points written by AI from the headline and a short excerpt, so they can be incomplete or wrong. MIT Technology Review did the reporting; read the original for the full story.
Read the full story at MIT Technology Review
